{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:59:57Z","timestamp":1793897997035,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["DP2-TMU-112-C-03"],"award-info":[{"award-number":["DP2-TMU-112-C-03"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2113-M-038-001"],"award-info":[{"award-number":["112-2113-M-038-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118215","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:51:58Z","timestamp":1758941518000},"page":"118215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoids"],"prefix":"10.1016","volume":"301","author":[{"given":"Iin","family":"Narwanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Yao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidyadhar","family":"Sethy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hsin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Bau","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-6405","authenticated-orcid":false,"given":"Jing-Ping","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118215_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2024.100739","article-title":"Anti-leukemia effects of ginsenoside monomer: a narrative review of pharmacodynamics study","author":"Dana","year":"2024","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.ejmech.2025.118215_bib2","article-title":"Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia","volume":"261","author":"Niu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib3","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2025.118215_bib4","article-title":"Disease burden, risk factors, and trends of leukaemia: a global analysis","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118215_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020641","article-title":"Targeted therapy development in acute myeloid leukemia","volume":"11","author":"Totiger","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.118215_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.659253","article-title":"Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"11","author":"van Gils","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118215_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.14740\/jmc3510","article-title":"Therapeutic challenges in chronic myeloid leukemia: a case-based discussion","volume":"11","author":"Perez","year":"2020","journal-title":"J. Med. Cases"},{"key":"10.1016\/j.ejmech.2025.118215_bib8","series-title":"Progress in Cell Cycle Research","first-page":"107","article-title":"Cell cycle regulation by the Cdc25 phosphatase family","author":"Nilsson","year":"2000"},{"key":"10.1016\/j.ejmech.2025.118215_bib9","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/MCB.25.7.2853-2860.2005","article-title":"Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases","volume":"25","author":"Ferguson","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118215_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2025.118215_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrc2169","article-title":"CDC25 phosphatases in cancer cells: key players? Good targets?","volume":"7","author":"Boutros","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118215_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200812045","article-title":"The decision to enter mitosis: feedback and redundancy in the mitotic entry network","volume":"185","author":"Lindqvist","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118215_bib13","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/bi700026j","article-title":"Cdc25 phosphatases: structure, specificity, and mechanism","volume":"46","author":"Rudolph","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118215_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12935-020-01304-w","article-title":"The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2025.118215_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/187152008786847756","article-title":"Cell cycle control by the CDC25 phosphatases","volume":"8","author":"Aressy","year":"2008","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib16","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.5706","article-title":"CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia","volume":"6","author":"Bertoli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118215_bib17","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1158\/0008-5472.CAN-05-2552","article-title":"Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia","volume":"66","author":"Fernandez-Vidal","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118215_bib18","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41598-020-58651-x","article-title":"STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia","volume":"10","author":"Sueur","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118215_bib19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3109\/10428194.2013.856007","article-title":"The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan","volume":"55","author":"Song","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2025.118215_bib20","first-page":"881","article-title":"In vitro anti-inflammatory and anticancer activities of extracts of Acalypha alopecuroidea (Euphorbiaceae)","volume":"35","author":"Madlener","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2025.118215_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.phymed.2009.06.001","article-title":"In vitro anti-leukemic activity of the ethno-pharmacological plant Scutellaria orientalis ssp. carica endemic to western Turkey","volume":"17","author":"Ozmen","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118215_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028011","article-title":"Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia","volume":"6","author":"Nakamura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118215_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bjh.12611","article-title":"Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect","volume":"164","author":"Reikvam","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmech.2025.118215_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/10428190801971690","article-title":"Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes","volume":"49","author":"Caudill","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2025.118215_bib25","doi-asserted-by":"crossref","first-page":"18414","DOI":"10.3390\/molecules191118414","article-title":"Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms","volume":"19","author":"Brenner","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118215_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12885-018-5220-x","article-title":"Shikonin inhibits cancer cell cycling by targeting Cdc25s","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2025.118215_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00531","article-title":"Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site","volume":"6","author":"Zhang","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ab.2012.08.006","article-title":"Development of a matrix-assisted laser desorption\/ionization\u2013mass spectrometry screening test to evidence reversible and irreversible inhibitors of CDC25 phosphatases","volume":"430","author":"Sibille","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2025.118215_bib29","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1016\/j.bmc.2012.05.040","article-title":"Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases","volume":"20","author":"Mak","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib30","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1016\/j.bmcl.2009.05.078","article-title":"Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors","volume":"19","author":"Park","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118215_bib31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ejmech.2016.05.060","article-title":"Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I","volume":"122","author":"Meng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib32","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/ijc.24080","article-title":"IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells","volume":"124","author":"Brezak","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118215_bib33","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ejmech.2010.02.009","article-title":"Cytotoxicity of new alkylamino- and phenylamino-containing polyfluorinated derivatives of 1,4-naphthoquinone","volume":"45","author":"Zakharova","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2014.05.063","article-title":"Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate","volume":"82","author":"Song","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib35","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0959-8049(99)00156-2","article-title":"Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase","volume":"35","author":"Wu","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118215_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111696","article-title":"Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries","volume":"183","author":"Jing","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105254","article-title":"Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries","volume":"115","author":"Tao","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib38","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/1535-7163.MCT-05-0168","article-title":"Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases","volume":"4","author":"Brezak","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2025.118215_bib39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0026-895X(24)12321-8","article-title":"Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors","volume":"61","author":"Lazo","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118215_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115505","article-title":"6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancers","volume":"258","author":"Narwanti","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib41","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/zaac.201900063","article-title":"The synthesis of quinoline-based tin complexes with Pendant Schiff bases","volume":"645","author":"Butler","year":"2019","journal-title":"Z. Anorg. Allg. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bmcl.2008.10.131","article-title":"Synthesis and antifungal activity of 1H-pyrrolo[3,2-g]quinoline-4,9-diones and 4,9-dioxo-4,9-dihydro-1H-benzo[f]indoles","volume":"19","author":"Ryu","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118215_bib43","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1021\/acs.jmedchem.2c01920","article-title":"Structural modification and pharmacological evaluation of substituted quinoline-5,8-diones as potent NSD2 onhibitors","volume":"66","author":"Tang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib44","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1016\/S0040-4039(00)01278-8","article-title":"The regioselectivity in the reaction of 6,7-dihaloquinoline-5,8-diones with amine nucleophiles in various solvents","volume":"41","author":"Yoon","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.118215_bib45","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1021\/cb500515r","article-title":"Small-molecule inhibitors of SETD8 with cellular activity","volume":"9","author":"Blum","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118215_bib46","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/nar\/gkt012","article-title":"Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity","volume":"41","author":"J\u00f8rgensen","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118215_bib47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/MCB.01517-07","article-title":"Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle","volume":"28","author":"Pesavento","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118215_bib48","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1128\/MCB.01768-08","article-title":"Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development","volume":"29","author":"Oda","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118215_bib49","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1038\/sj.emboj.7600469","article-title":"The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle","volume":"23","author":"Aylon","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.118215_bib50","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1074\/jbc.M808906200","article-title":"Human CtIP mediates cell cycle control of DNA end resection and double strand break repair","volume":"284","author":"Huertas","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118215_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003277","article-title":"The interaction of CtIP and Nbs1 connects CDK and ATM to regulate HR-mediated double-strand break repair","volume":"9","author":"Wang","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejmech.2025.118215_bib52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1083\/jcb.200903033","article-title":"Overall Cdk activity modulates the DNA damage response in mammalian cells","volume":"187","author":"Cerqueira","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118215_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1101\/gad.177444.111","article-title":"PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription","volume":"26","author":"Beck","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2025.118215_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118215_bib55","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:40:36Z","timestamp":1773142836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S0223523425009808"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118215","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoids","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118215"}}